Thyme Care, a value-based cancer care company, has secured $97 million in Series D funding to scale its platform to more patients, it announced on Thursday.

Nashville, Tennessee-based Thyme Care , founded in 2020, partners with health plans, employers and risk-bearing providers to support patients battling cancer. It offers care navigation services, technology and data insights and therapeutic interventions. The company helps patients understand their diagnosis, find a cancer doctor and receive clinical care between appointments. Patients also gain access to a team of providers, nurses and resource specialists. Its services are available to 8 million people across all 50 states.

The Series D round included participation from CVS Health Ventures, Foresite Capital, a16z Bio + Health, C

See Full Page